In order to follow the same layout as the previous work and to know the efficacy of IGS2.7 in ALS treatment, lymphoblasts were treated with the compound at 5 μM, which is the concentration known to reduce TDP-43 phosphorylation. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.